Levalox

Levofloxacin, the active ingredient in Levalox, is a Fluoroquinolone presented as an oral dosage form for systemic use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Levalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum antibacterial indicated for several acute bacterial infections.

Community‑acquired pneumonia: effective treatment of susceptible bacterial pathogens causing lung infection. Acute bacterial sinusitis: eradicates causative organisms to relieve sinus inflammation. Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load during flare‑ups. Uncomplicated urinary tract infections: clears infection in the lower urinary tract. Complicated urinary tract infections: targets resistant bacteria in upper or complicated UTIs. Skin and soft tissue infections: combats susceptible skin‑borne bacteria.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or upset stomach. - Diarrhea or loose stools. - Headache. - Dizziness. - Abdominal discomfort. - Insomnia.

Serious or Rare Side Effects: - Tendon rupture or inflammation. - QT interval prolongation on ECG. - Severe allergic reactions such as Stevens‑Johnson syndrome. - Clostridioides difficile‑associated colitis. - Peripheral neuropathy. - Hepatic toxicity.

Levofloxacin should be used with caution in specific clinical situations.

Assess renal function: dose adjustment may be required in impaired kidney function. Avoid in patients with known tendon disorders: risk of tendon rupture is increased. Use cautiously in elderly patients: higher incidence of adverse events. Review concomitant QT‑prolonging drugs: potential for cardiac arrhythmias. Store at room temperature: keep in original packaging, protect from moisture and light.

Levofloxacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely): - Theophylline: may increase plasma levels, requiring monitoring. - Cyclosporine: potential for increased nephrotoxicity.